Inventor · disambiguated record
Abhinandini Sharma
Also filed as: SHARMA ABHINANDINI
4 granted patents·3 pending applications·27 citations·filing 2010–2017
74Inventor score
Files withALFARO-LOPEZ JOSUE2AMYLIN PHARMACEUTICALS LLC2ERICKSON MARY2ASTRAZENECA PHARMACEUTICALS LP1
Top patents by PatentIndex Score
7 records- 0186US8642544B2N-terminus conformationally constrained GLP-1 receptor agonist compoundsALFARO-LOPEZ JOSUE·Filed 2010·Granted Feb 4, 2014·14 cites·3 claims
- 0278US9593154B2Engineered polypeptides having enhanced duration of actionAMYLIN PHARMACEUTICALS LLC·Filed 2013·Granted Mar 14, 2017·4 cites·10 claims
- 0374US9382304B2Engineered polypeptides having enhanced duration of action with reduced immunogenicityERICKSON MARY·Filed 2012·Granted Jul 5, 2016·6 cites·11 claims
- 0470US9217022B2GLP-1 receptor agonist compounds having stabilized regionsALFARO-LOPEZ JOSUE·Filed 2011·Granted Dec 22, 2015·3 cites·2 claims
- 0543US2014162943A1N-terminus conformationally constrained glp-1 receptor agonist compoundsASTRAZENECA PHARMACEUTICALS LP·Filed 2014·Application pending·0 cites
- 0643US2017114114A1Engineered polypeptides having enhanced duration of actionAMYLIN PHARMACEUTICALS LLC·Filed 2017·Application pending·0 cites
- 0736US2018344813A1Engineered polypeptides having enhanced duration of action with reduced immunogenicityERICKSON MARY·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Abhinandini Sharma files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →